Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalfurafine HCl in Hemodialysis Patients with Uremic Pruritus
NCT00793156Phase 3Unknown
- Sponsor
- Acologix
- Start
- Dec 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of nalfurafine in uremic pruritus (3 arms), sponsored by Acologix. Primary endpoint: Change in worst itching intensity from baseline at 11 weeks. Status: unknown.
02
Drugs
nalfurafine
03
Conditions
uremic pruritus
Beyond the preview
Go deeper on NCT00793156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00793156.